NEW YORK – A Finnish research team has started to trace the immune shifts that coincide with the presence of hematological malignancies such as multiple myeloma, lymphoma, leukemia, or myelodysplastic syndrome in an effort to better understand the biology of the conditions as well as potential immune-based treatment strategies.